• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用一种选择性点击化学方法对抗体的 N-末端α-氨基进行修饰。

N-terminal α-amino group modification of antibodies using a site-selective click chemistry method.

机构信息

a Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center , Guangdong , China.

b Department of Development Technology of Marine Resources , School of Life Science, Zhejiang Sci-Tech University , Zhejiang , China.

出版信息

MAbs. 2018 Jul;10(5):712-719. doi: 10.1080/19420862.2018.1463122.

DOI:10.1080/19420862.2018.1463122
PMID:29652547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6150616/
Abstract

Site-specific conjugation of small molecules to antibody molecules is a promising strategy for generation of antibody-drug conjugates. In this report, we describe the successful synthesis of a novel bifunctional molecule, 6-(azidomethyl)-2-pyridinecarboxyaldehyde (6-AM-2-PCA), which was used for conjugation of small molecules to peptides and antibodies. We demonstrated that 6-AM-2-PCA selectively reacted with N-terminal amino groups of peptides and antibodies. In addition, the azide group of 6-AM-2-PCA enabled copper-free click chemistry coupling with dibenzocyclooctyne-containing reagents. Bifunctional 6-AM-2-PCA mediated site-specific conjugation without requiring genetic engineering of peptides or antibodies. A key advantage of 6-AM-2-PCA as a conjugation reagent is its ability to modify proteins in a single step under physiological conditions that are sufficiently moderate to retain protein function. Therefore, this new click chemistry-based method could be a useful complement to other conjugation methods.

摘要

小分子的定点偶联到抗体分子是一种很有前途的生成抗体-药物偶联物的策略。在本报告中,我们描述了一种新型双功能分子 6-(叠氮甲基)-2-吡啶甲醛(6-AM-2-PCA)的成功合成,该分子可用于小分子与肽和抗体的偶联。我们证明了 6-AM-2-PCA 选择性地与肽和抗体的 N 端氨基反应。此外,6-AM-2-PCA 的叠氮基团能够与含二苯并环辛炔的试剂进行无铜点击化学偶联。双功能 6-AM-2-PCA 介导的定点偶联不需要对肽或抗体进行基因工程。6-AM-2-PCA 作为偶联试剂的一个关键优势是,它能够在生理条件下一步修饰蛋白质,条件足够温和,能够保留蛋白质的功能。因此,这种新的基于点击化学的方法可能是其他偶联方法的有用补充。

相似文献

1
N-terminal α-amino group modification of antibodies using a site-selective click chemistry method.使用一种选择性点击化学方法对抗体的 N-末端α-氨基进行修饰。
MAbs. 2018 Jul;10(5):712-719. doi: 10.1080/19420862.2018.1463122.
2
Synthesis of precision antibody conjugates using proximity-induced chemistry.利用邻近诱导化学合成精准抗体偶联物。
Theranostics. 2021 Aug 27;11(18):9107-9117. doi: 10.7150/thno.62444. eCollection 2021.
3
Highly robust and optimized conjugation of antibodies to nanoparticles using quantitatively validated protocols.采用经定量验证的方案实现抗体与纳米颗粒的高度稳健和优化偶联。
Nanoscale. 2017 Feb 16;9(7):2548-2555. doi: 10.1039/c6nr04683e.
4
Preparation of single- and double-oligonucleotide antibody conjugates and their application for protein analytics.单链和双链寡核苷酸抗体缀合物的制备及其在蛋白质分析中的应用。
Sci Rep. 2020 Jan 29;10(1):1457. doi: 10.1038/s41598-020-58238-6.
5
Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry.哺乳动物细胞中含叠氮化物的基因编码氨基酸利用点击环加成化学实现位点特异性抗体-药物偶联物。
Bioconjug Chem. 2015 Nov 18;26(11):2249-60. doi: 10.1021/acs.bioconjchem.5b00359. Epub 2015 Sep 11.
6
Site-Specific Antibody Conjugation with Payloads beyond Cytotoxins.靶向抗体药物偶联物:超越细胞毒素的Payload 研究
Molecules. 2023 Jan 17;28(3):917. doi: 10.3390/molecules28030917.
7
Click Chemistry Conjugations.点击化学共轭反应
Methods Mol Biol. 2020;2078:83-97. doi: 10.1007/978-1-4939-9929-3_6.
8
Parallel synthesis and screening of peptide conjugates.肽缀合物的平行合成与筛选。
Bioconjug Chem. 2014 Jun 18;25(6):1052-60. doi: 10.1021/bc500129w. Epub 2014 May 13.
9
General and Robust Chemoenzymatic Method for Glycan-Mediated Site-Specific Labeling and Conjugation of Antibodies: Facile Synthesis of Homogeneous Antibody-Drug Conjugates.通用且稳健的聚糖介导的抗体定点标记和偶联的酶促化学方法:均一抗体药物偶联物的简便合成。
ACS Chem Biol. 2021 Nov 19;16(11):2502-2514. doi: 10.1021/acschembio.1c00597. Epub 2021 Sep 27.
10
Preparation of bispecific antibody-protein adducts by site-specific chemo-enzymatic conjugation.通过定点化学酶促偶联制备双特异性抗体-蛋白质缀合物。
Methods. 2019 Feb 1;154:93-101. doi: 10.1016/j.ymeth.2018.07.013. Epub 2018 Aug 3.

引用本文的文献

1
Recent Progress in Antibody Epitope Prediction.抗体表位预测的最新进展
Antibodies (Basel). 2023 Aug 8;12(3):52. doi: 10.3390/antib12030052.
2
Real-time imaging of cell-surface proteins with antibody-based fluorogenic probes.基于抗体的荧光探针用于细胞表面蛋白的实时成像。
Chem Sci. 2021 Sep 16;12(40):13477-13482. doi: 10.1039/d1sc03065e. eCollection 2021 Oct 20.
3
Herding cats: Label-based approaches in protein translocation through nanopore sensors for single-molecule protein sequence analysis.像赶猫一样难:基于标签的方法用于通过纳米孔传感器进行蛋白质转位以实现单分子蛋白质序列分析
iScience. 2021 Aug 25;24(9):103032. doi: 10.1016/j.isci.2021.103032. eCollection 2021 Sep 24.
4
Site-specific conjugation of native antibody.天然抗体的位点特异性缀合
Antib Ther. 2020 Dec;3(4):271-284. doi: 10.1093/abt/tbaa027. Epub 2020 Dec 18.
5
Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer.用嵌合抗原受体工程化自然杀伤细胞靶向B7-H3免疫检查点对非小细胞肺癌显示出强大的细胞毒性。
Front Pharmacol. 2020 Jul 30;11:1089. doi: 10.3389/fphar.2020.01089. eCollection 2020.
6
Building Potent Chimeric Antigen Receptor T Cells With CRISPR Genome Editing.利用 CRISPR 基因组编辑技术构建强效嵌合抗原受体 T 细胞
Front Immunol. 2019 Mar 19;10:456. doi: 10.3389/fimmu.2019.00456. eCollection 2019.

本文引用的文献

1
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs).抗体药物偶联物(ADC)设计与功能的抗体结构及工程学考量
Oncoimmunology. 2017 Nov 20;7(3):e1395127. doi: 10.1080/2162402X.2017.1395127. eCollection 2018.
2
Antibody drug conjugates: the future of chemotherapy?抗体药物偶联物:化疗的未来?
Curr Opin Oncol. 2016 Sep;28(5):429-36. doi: 10.1097/CCO.0000000000000310.
3
Antibody drug conjugates.抗体药物偶联物
Biotechnol Lett. 2016 Oct;38(10):1655-64. doi: 10.1007/s10529-016-2160-x. Epub 2016 Jun 22.
4
Antibody-drug conjugates for cancer therapy.用于癌症治疗的抗体药物偶联物。
Lancet Oncol. 2016 Jun;17(6):e254-e262. doi: 10.1016/S1470-2045(16)30030-4.
5
Recent advances in the construction of antibody-drug conjugates.抗体偶联药物构建的最新进展。
Nat Chem. 2016 Feb;8(2):114-9. doi: 10.1038/nchem.2415. Epub 2016 Jan 4.
6
Antibody-drug conjugates--an emerging class of cancer treatment.抗体药物偶联物——一类新兴的癌症治疗药物。
Br J Cancer. 2016 Feb 16;114(4):362-7. doi: 10.1038/bjc.2015.435. Epub 2016 Jan 7.
7
Antibody-drug conjugates as novel anti-cancer chemotherapeutics.抗体药物偶联物作为新型抗癌化疗药物。
Biosci Rep. 2015 Jun 12;35(4):e00225. doi: 10.1042/BSR20150089.
8
N-terminal modifications of cellular proteins: The enzymes involved, their substrate specificities and biological effects.细胞蛋白质的N端修饰:相关酶、其底物特异性及生物学效应
Proteomics. 2015 Jul;15(14):2385-401. doi: 10.1002/pmic.201400619. Epub 2015 Jun 16.
9
Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8.静电表面电位的改变增强了抗神经节苷脂GD2单克隆抗体hu3F8的亲和力和肿瘤杀伤特性。
J Biol Chem. 2015 May 22;290(21):13017-27. doi: 10.1074/jbc.M115.650903. Epub 2015 Apr 7.
10
One-step site-specific modification of native proteins with 2-pyridinecarboxyaldehydes.一步法定点修饰天然蛋白质的 2-吡啶甲酰醛。
Nat Chem Biol. 2015 May;11(5):326-31. doi: 10.1038/nchembio.1792. Epub 2015 Mar 30.